-

MedImpact Achieves NCQA UM Accreditation Three-Year Renewal

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefit and health solutions company, announced today that it has earned a three-year reaccreditation in Utilization Management from the National Committee for Quality Assurance (NCQA). This marks MedImpact’s fourth consecutive NCQA UM Accreditation.

“Achieving NCQA Utilization Management Accreditation demonstrates that MedImpact has the systems, processes, and personnel in place to conduct utilization management in accordance with the strictest quality standards,” stated Margaret E. O’Kane, President, NCQA.

NCQA is an independent, nonprofit organization dedicated to improving healthcare quality through voluntary, objective, and evidence-based evaluations. NCQA accreditation is a key critical differentiator for pharmacy benefit managers (PBMs) seeking to partner with health plans, managed care organizations, and accountable care organizations.

“For more than 35 years, MedImpact has ensured timely access to medications and supported improved health outcomes by putting our clients and members at the center of care,” said Denise Burns, Chief Operations Officer at MedImpact. “NCQA represents the gold standard in healthcare quality, and this recognition reflects our continued commitment to clinical excellence, responsible utilization, and delivering connected care that supports both quality and affordability.”

MedImpact continues to lead the way in clinical innovation, investing heavily in a world-class clinical team, and delivering personalized care solutions. This forward-thinking approach drives effective utilization management, high-touch member engagement, and low year-over-year cost trend. Today, MedImpact supports more than 55 million consumers globally, including many of the nation’s most recognizable health plans and self-insured employers.

“MedImpact’s successful NCQA UM Accreditation renewal and continued URAC PBM Accreditation validate the integrity of our clinical programs and operational excellence, reinforce our commitment to uphold the highest standards of quality and transparency, and reaffirm our position as a trusted healthcare leader,” Burns said.

NCQA has reviewed and accredited MedImpact’s Utilization Management functions only. For complete details on the scope of this review, visit www.ncqa.org.

About MedImpact

MedImpact Healthcare Systems, Inc., based in San Diego, is the nation’s largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has partnered with commercial and government healthcare payers to improve member health, manage pharmacy benefits, and reduce drug costs. The company serves more than 55 million consumers globally and processes over $40 billion in pharmacy transactions annually. To learn more, visit us online, follow us on LinkedIn, or contact us at info@MedImpact.com.

About NCQA

NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in healthcare. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make more informed health care choices. NCQA can be found online at ncqa.org, on X (Twitter) @ncqa, on Facebook at facebook.com/NCQA.org/ and on LinkedIn at linkedin.com/company/ncqa.

Contacts

MedImpact Healthcare Systems, Inc.


Release Versions

Contacts

Social Media Profiles
More News From MedImpact Healthcare Systems, Inc.

MedImpact Offers Humira Biosimilar 95% Below the Cost of Humira to Any Hospital or Pharmacy

SAN DIEGO--(BUSINESS WIRE)--MedImpact Holdings, Inc. today announced the launch of an unbranded biosimilar to Humira® (adalimumab) priced at 95% below the brand-name cost. MedImpact is offering this biosimilar (Adalumymab-ryvk), manufactured by Anda, an affiliate of Teva Pharmaceuticals USA, Inc., through its preferred partner, Birdi Inc., to any hospital, plan, or pharmacy nationwide—not just its own clients or affiliates. “For too long, the industry has used supply chain complexity to inflate...

MedImpact Completes Acquisition of Sav-Rx

SAN DIEGO--(BUSINESS WIRE)--MedImpact Healthcare Systems, Inc., the nation’s largest independent pharmacy benefit and health solutions company, today announced the completion of its acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The transaction strengthens MedImpact’s ability to serve a broad range of clients by adding specialized expertise, scale, and deep insight into a key market segment. Sav-Rx will continue to operate in...

MedImpact Unveils Innovative PMPM Guarantee Model

SAN DIEGO--(BUSINESS WIRE)--MedImpact, the nation’s largest independent pharmacy benefits technology and health solutions provider, today announced the launch of MedImpact OnePrice™, a new approach to prescription drug cost containment that offers clients a predictable, transparent, and performance-backed Per Member, Per Month (PMPM) pricing model. Unlike other guarantees on the market, MedImpact stands firmly behind its commitment—putting its entire administrative fee at risk to ensure clients...
Back to Newsroom